Abbott is recalling its Proclaim and Infinity IPGs due to complaints from patients who are unable to exit MRI mode, noted the FDA, which identifies July 18 as the date the recall was initiated by the firm. “The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death,” the recall notice posted today to the FDA site stated.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABT:
- Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes
- Abbott to acquire Bigfoot for undisclosed amount
- Jefferies healthcare analyst holds an analyst/industry conference call
- FDA clears Abbott’s Alinity h-series hematology system
- Fly Insider: Yellow Corp, Abbott Labs among week’s notable insider trades